| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥2.70B | -9.6% |
| Gross profit | ¥0.05B | — |
| Operating income | ¥-0.44B | — |
| Net income | ¥-0.36B | — |
| Gross margin | 2.0% | Net margin -13.4% |
| Revenue Q/Q | +27.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥2.65B | 98.0% |
| R&D | ¥0.05B | 1.9% |
| SG&A | ¥0.25B | 9.4% |
| Tax & other | ¥-0.08B | -3.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
瑞普生物 ・ 经纬辉开 ・ 阳谷华泰 ・ ST亚光 ・ *ST聆达 ・ 锐奇股份 ・ 银河磁体 ・ 锦富技术 ・ 泰胜风能 ・ 新国都 ・ 英唐智控 ・ 青松股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies